Chairs: Martina Severa (ISS – Rome, Italy) & Claudio Procaccini (EOS-CNR – Naples, Italy) & Rosella Mechelli (IRCCS San Raffaele – Rome, Italy)
699 | IL-1β Contributes to Neurological Disability in NMOSD AQP4+ Patients
Antonio Bruno (IRCSS Neuromed – Pozzilli, Italy)
701 | Leishmania infantum Infection Inhibits NLRP3 Inflammasome Activation: An In Vitro Model for Investigating Neuroinflammation in Microglia
Francesca La Rosa (IRCCS Fondazione Don Carlo Gnocchi – Milan, Italy)
702 | Fc-glycosylation profiles in NMDAR encephalitis identify brain-compartmentalized antibody responses, predict outcomes and track with post-herpetic, tumor-related or idiopathic origin.
Marianna Spatola (University of Barcelona, Spain and Caixa Research Institute (CRI) – Barcelona, Spain)
704 | Meningeal inflammation and tertiary lymphoid-like structure as secreted hideout of latent Epstein-Barr virus infection inducing B cell expansion in multiple sclerosis
Benedetta Bellini (University of Verona – Verona, Italy)
705 | Research of anti-acetylcholine antibodies using different methods in patients clinically compatible with Myasthenia Gravis.
Anastasia Lechiara (IRCCS Ospedale Policlinico San Martino – Genoa, Italy)
708 | INVESTIGATING THE INTERACTION BETWEEN THE GENETIC RISK VARIANT BAFF-VAR AND EBV REACTIVATION IN MULTIPLE SCLEROSIS: IMPLICATIONS FOR IMMUNE DYSREGULATION
Chiara Meloni (Istituto Superiore di Sanità – Rome, Italy)
713 | Epstein-Barr virus DNA detection in brain tissue sections from donors with progressive multiple sclerosis
LUCIA BENINCASA (Istituto Superiore di Sanità – Rome, Italy)
721 | Understanding Acute Symptomatic Seizure secondary to Autoimmune Encephalitis: a new experimental in vitro approach.
Alessio Passalacqua (Charitè-Universitatsmedizin – Berlin, Germany)
728 | Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis
Luana Benedetti (IRCCS Ospedale Policlinico San Martino – Genoa, Italy)
729 | Characterization of virus-induced bystander T cells in multiple sclerosis patients
Alice Verdiani (IRCSS Fondazione Santa Lucia – Rome, Italy)
730 | advancing neuromyelitis optica spectrum disorder therapy through antigen-specific regulatory t cells enrichment and cryopreservation
Sara Cestari (Experimental and Clinical Research Center (ECRC)/Charité-Universitätsmedizin/Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) – Berlin, Germany)
732 | Analysis of an innovative fluid biomarker panel for early prediction of Progression Independent of Relapse Activity (PIRA) in Multiple Sclerosis (MS)
Edoardo Dalmato Schilke (Fondazione IRCCS San Gerardo Dei Tintori – Monza, Italy/University of Milano-Bicocca – Milan, Italy)
734 | Early network and behavioral dysfunctions in experimental neuroinflammation: the role of IFN-gamma
Laura Bellingacci (Unviersity of Perugia – Perugia, Italy)
745 | Association Between Schizophrenia Severity and Inflammatory Biomarkers: A Hospital-Based Cross-Sectional Comparative Study
susanna de stefano (Tor Vergata University Hospital/University of Rome Tor Vergata – Rome, Italy)
747 | Extracellular vesicles enhance IL4 anti-inflammatory properties in BV2 murine microglial cell line
Chiara Frigè (IRCCS Ospedale San Raffaele – Milan, Italy)
748 | the dual role of btk inhibitors in multiple sclerosis treatment: clinical efficacy and modulation of ebv-host interactions
yuanyuan zou (Università La Sapienza – Rome, Italy)
750 | Effectiveness and Safety of Cladribine in a Real-World Multiple Sclerosis Cohort: A Single-Center Retrospective Study
Sabrina Al Qudsi (University of Genoa – Genoa, Italy)
751 | Sex differences in the humoral response to vaccine in multiple sclerosis a meta-analysis
Davide Maioli (University of Genoa – Genoa, Italy)
755 | Vaccination with Mycobacterium Tuberculosis protects from autoimmune neuroinflammation.
Alessia Lupoli (IRCCS Ospedale San Raffaele – Milan, Italy)
758 | Response to diphtheria and pertussis vaccination in untreated or anti-CD20 exposed Multiple Sclerosis pregnant women
Lisa De Pasquale (Istituto Superiore di Sanità – Rome, Italy/University of Modena and Reggio Emilia – Modena, Italy)
766 | Effects of Ozanimod on T cell – mediated synaptic excitotoxicity in relapsing-remitting multiple sclerosis.
Federica Palmerio (University of Rome Tor Vergata/IRCCS San Raffaele Roma – Rome, Italy)
768 | John Cunningham Virus (JCV) serostatus discrepancy by two different tests: impact on the clinicians and patients choices in a cohort Multiple Sclerosis patients treated with natalizumab
Paola Cavalla (University of Turin/AOU Città della Salute e della Scienza – Turin, Italy)
769 | Longitudinal changes in gut microbiome composition in individuals with Multiple Sclerosis undergoing Dimethyl Fumarate therapy: a one-year follow-up study
Rachele Rosso (University of Turin – Orbassano, Italy)
770 | Comparative Analysis of Paranodal Antibody Assays in Autoimmune Nodopathies: Diagnostic Accuracy and Inter-Laboratory Agreement
Federica Zuliani (IRCCS Mondino Foundation – Pavia, Italy)
775 | Physical exercise modulates T cell-mediated excitotoxicity in multiple sclerosis: a potential role for the vagus nerve
alessandra Musella (University of Rome San Raffaele/IRCCS San Raffaele Roma – Rome, Italy)
781 | Diet-Induced Metabolic Reprogramming Alters Immune Responses and Disease Progression in EAE
Vincenzo Di Marino (Università di Napoli “Federico II” – Naples, Italy)
786 | ANALYSIS OF THE MODULATION AND ABLATION OF S100B GENE ON GLIAL CELLS: EFFECTS ON MULTIPLE SCLEROSIS
Mariangela Ruggirello (University of Perugia – Perugia, Italy/University “Cattolica del Sacro Cuore” of Rome – Rome, Italy)
788 | KFLC index performance across MS spectrum: a monocentric study
Francesca Napoli (Tor Vergata University Hospital – Rome, Italy)
789 | Low immunoglobulin G levels influence the risk of pneumonia in a real-world cohort of Multiple Sclerosis patients treated with anti CD20 monoclonal Antibodies
Paola Cavalla (University of Turin/Health and Science City University Hospital of Turin – Turin, Italy)
